U.S. flag

An official website of the United States government

NM_003000.3(SDHB):c.304G>A (p.Ala102Thr) AND Hereditary cancer-predisposing syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jul 13, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001018296.5

Allele description [Variation Report for NM_003000.3(SDHB):c.304G>A (p.Ala102Thr)]

NM_003000.3(SDHB):c.304G>A (p.Ala102Thr)

Gene:
SDHB:succinate dehydrogenase complex iron sulfur subunit B [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p36.13
Genomic location:
Preferred name:
NM_003000.3(SDHB):c.304G>A (p.Ala102Thr)
HGVS:
  • NC_000001.11:g.17028719C>T
  • NG_012340.1:g.30452G>A
  • NM_003000.3:c.304G>AMANE SELECT
  • NP_002991.2:p.Ala102Thr
  • LRG_316t1:c.304G>A
  • LRG_316:g.30452G>A
  • NC_000001.10:g.17355214C>T
  • NC_000001.10:g.17355214C>T
  • NM_003000.2:c.304G>A
Protein change:
A102T; ALA102THR
Links:
OMIM: 185470.0024; dbSNP: rs777578399
NCBI 1000 Genomes Browser:
rs777578399
Molecular consequence:
  • NM_003000.3:c.304G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001179515Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Jul 13, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Novel variant p.(Ala102Thr) in SDHB causes mitochondrial complex II deficiency: Case report and review of the literature.

Kaur P, Sharma S, Kadavigere R, Girisha KM, Shukla A.

Ann Hum Genet. 2020 Jul;84(4):345-351. doi: 10.1111/ahg.12377. Epub 2020 Mar 2. Review.

PubMed [citation]
PMID:
32124427

Spectrum and management of breast cancer patients with variant of uncertain significance mutations at a tertiary care centre in North India.

Mittal A, Deo SVS, Gogia A, Batra A, Kumar A, Bhoriwal S, Deb KS, Dhamija E, Ramprasad VL, Olopade O, Pramanik R.

Ecancermedicalscience. 2022;16:1434. doi: 10.3332/ecancer.2022.1434.

PubMed [citation]
PMID:
36200007
PMCID:
PMC9470172

Details of each submission

From Ambry Genetics, SCV001179515.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

The p.A102T variant (also known as c.304G>A), located in coding exon 4 of the SDHB gene, results from a G to A substitution at nucleotide position 304. The alanine at codon 102 is replaced by threonine, an amino acid with similar properties. This alteration has been reported in the homozygous state in an individual with Leigh syndrome (Kaur P et al. Ann Hum Genet, 2020 Jul;84:345-351). This alteration has also been reported in a breast cancer cohort from India (Mittal A et al. Ecancermedicalscience, 2022 Aug;16:1434). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024